SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009672
Filing Date
2020-08-06
Accepted
2020-08-06 16:22:11
Documents
93
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200630x10q.htm   iXBRL 10-Q 2046971
2 EX-31.1 tmb-20200630xex31d1.htm EX-31.1 9711
3 EX-31.2 tmb-20200630xex31d2.htm EX-31.2 9759
4 EX-32.1 tmb-20200630xex32d1.htm EX-32.1 7935
  Complete submission text file 0001558370-20-009672.txt   9088105

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20200630.xsd EX-101.SCH 89568
6 EX-101.CAL tmb-20200630_cal.xml EX-101.CAL 53612
7 EX-101.DEF tmb-20200630_def.xml EX-101.DEF 344964
8 EX-101.LAB tmb-20200630_lab.xml EX-101.LAB 570263
9 EX-101.PRE tmb-20200630_pre.xml EX-101.PRE 570029
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200630x10q_htm.xml XML 1513391
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 201082036
SIC: 2834 Pharmaceutical Preparations